Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER, RE-COVER II, and RE-MEDY
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 February 2017
|
| In: |
Journal of thrombosis and thrombolysis
Year: 2017, Jahrgang: 43, Heft: 4, Pages: 484-489 |
| ISSN: | 1573-742X |
| DOI: | 10.1007/s11239-017-1479-z |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s11239-017-1479-z Verlag, Volltext: https://doi.org/10.1007/s11239-017-1479-z 
|
| Verfasserangaben: | Martin Feuring, Sam Schulman, Henry Eriksson, Ajay J. Kakkar, Sebastian Schellong, Stefan Hantel, Elke Schueler, Jörg Kreuzer, Samuel Z. Goldhaber |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1582036780 | ||
| 003 | DE-627 | ||
| 005 | 20220815033021.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181017s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11239-017-1479-z |2 doi | |
| 035 | |a (DE-627)1582036780 | ||
| 035 | |a (DE-576)512036780 | ||
| 035 | |a (DE-599)BSZ512036780 | ||
| 035 | |a (OCoLC)1341019878 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Feuring, Martin |d 1963-2018 |e VerfasserIn |0 (DE-588)1075744083 |0 (DE-627)833665383 |0 (DE-576)176498125 |4 aut | |
| 245 | 1 | 0 | |a Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism |b analyses from RE-COVER, RE-COVER II, and RE-MEDY |c Martin Feuring, Sam Schulman, Henry Eriksson, Ajay J. Kakkar, Sebastian Schellong, Stefan Hantel, Elke Schueler, Jörg Kreuzer, Samuel Z. Goldhaber |
| 264 | 1 | |c 16 February 2017 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.10.2018 | ||
| 650 | 4 | |a Anticoagulant | |
| 650 | 4 | |a Dabigatran etexilate | |
| 650 | 4 | |a Venous thromboembolism | |
| 650 | 4 | |a Warfarin | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of thrombosis and thrombolysis |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1994 |g 43(2017), 4, Seite 484-489 |h Online-Ressource |w (DE-627)320578445 |w (DE-600)2017305-2 |w (DE-576)107930692 |x 1573-742X |7 nnas |a Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism analyses from RE-COVER, RE-COVER II, and RE-MEDY |
| 773 | 1 | 8 | |g volume:43 |g year:2017 |g number:4 |g pages:484-489 |g extent:6 |a Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism analyses from RE-COVER, RE-COVER II, and RE-MEDY |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11239-017-1479-z |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s11239-017-1479-z |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181017 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1075744083 |a Feuring, Martin |m 1075744083:Feuring, Martin |d 60000 |e 60000PF1075744083 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1582036780 |e 3029023885 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"part":{"volume":"43","text":"43(2017), 4, Seite 484-489","extent":"6","year":"2017","pages":"484-489","issue":"4"},"pubHistory":["1.1994/95 -"],"language":["eng"],"recId":"320578445","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism analyses from RE-COVER, RE-COVER II, and RE-MEDYJournal of thrombosis and thrombolysis","note":["Gesehen am 06.12.05","Ungezählte Beil.: Suppl"],"title":[{"title_sort":"Journal of thrombosis and thrombolysis","title":"Journal of thrombosis and thrombolysis","subtitle":"an international journal for clinicians and scientists"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2017305-2"],"eki":["320578445"],"issn":["1573-742X"]},"origin":[{"publisher":"Springer Science + Business Media B.V ; Kluwer","dateIssuedKey":"1994","dateIssuedDisp":"1994-","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]"}]}],"physDesc":[{"extent":"6 S."}],"name":{"displayForm":["Martin Feuring, Sam Schulman, Henry Eriksson, Ajay J. Kakkar, Sebastian Schellong, Stefan Hantel, Elke Schueler, Jörg Kreuzer, Samuel Z. Goldhaber"]},"id":{"doi":["10.1007/s11239-017-1479-z"],"eki":["1582036780"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"16 February 2017"}],"language":["eng"],"recId":"1582036780","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 17.10.2018"],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Feuring, Martin","given":"Martin","family":"Feuring"}],"title":[{"title_sort":"Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism","title":"Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism","subtitle":"analyses from RE-COVER, RE-COVER II, and RE-MEDY"}]} | ||
| SRT | |a FEURINGMARNETCLINICA1620 | ||